Literature DB >> 3292152

Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.

K Kühn1, B Nonnast-Daniel, P Grützmacher, J Grüner, W Pfåffl, C A Baldamus, P Scigalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3292152

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  3 in total

1.  Poor response to erythropoietin.

Authors:  I C Macdougall
Journal:  BMJ       Date:  1995-06-03

Review 2.  [Erythropoietin and hypertension].

Authors:  U Frei; B Nonnast-Daniel; K M Koch
Journal:  Klin Wochenschr       Date:  1988-09-15

Review 3.  Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.